FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
21 letters match. Newest first.
-
DrugsABS Corporation
ABS Corporation released out-of-specification veterinary drugs and used inadequately tested raw materials, FDA says.
High risk -
FoodImu-Tek Animal Health, Incorporated
FDA warns Imu-Tek Animal Health over unapproved drug claims and manufacturing failures for Colostrom-5 products.
High risk -
AnimalDK Hardware Supply
FDA warns DK Hardware Supply over unapproved, unlisted aquarium-fish antibiotic drugs.
High risk -
AnimalElanco Animal Health USA
FDA says Elanco's Pradalex ads misbrand the livestock antibiotic by claiming first-line use and "all relevant pathogen" coverage.
Medium -
DrugsChromatography Institute of America dba Compounder’s International Analytical Laboratory
FDA warned Chromatography Institute of America, a Colorado contract drug testing lab, that sterility testing and quality controls violated current good manufacturing practice.
High risk -
AnimalAurora Pharmaceutical
FDA told Aurora Pharmaceutical its websites and brochures for three animal drugs hid safety warnings, making the products misbranded.
Medium -
AnimalElanco Animal Health
FDA says Elanco's Zenrelia promotional materials omit or misstate safety warnings and study results, misbranding the veterinary drug.
High risk -
AnimalEvolution Pets LLC
Evolution Pets marketed SeizureGuard Plus and Life Span Arthritis & Mobility as unapproved drugs for treating dog diseases.
High risk -
AnimalNutrition Strength Ltd.
FDA warns Nutrition Strength Ltd. over unapproved dog seizure and blood-support supplements marketed as animal drugs.
High risk -
AnimalEnergetic Essences, LLC dba Pet Essences
FDA warned Pet Essences that its Seizures formula is an unapproved new animal drug marketed to treat seizures in animals.
High risk -
AnimalArdent Animal Health, LLC
Ardent Animal Health marketed Acti-Stem Therapy and PureVet PRP as unapproved new animal drugs for dogs and cats.
Medium -
Animal1 Stop Chicken Health Shop
FDA warns 1 Stop Chicken Health Shop over selling unapproved animal drugs, including toltrazuril and enrofloxacin, for poultry and other birds.
High risk -
AnimalBullyKamp Products LLC
BullyKamp Products LLC marketed unapproved animal drugs with disease-treatment claims on its website, FDA says.
High risk -
AnimalTop Dog Pet Store LLC dba The Bulldog Cartel
Top Dog Pet Store marketed Green Magic and Bulldog Cartel Parvo Combat as unapproved animal drugs for treating diseases.
High risk -
Animaltotaltoltrazuril.com
FDA warned totaltoltrazuril.com for selling Total Toltrazuril, an unapproved new animal drug, for coccidiosis and horse EPM.
High risk -
AnimalLinessa Farms, LLC
Linessa Farms markets unapproved toltrazuril animal drugs for coccidiosis, FDA warns after website review.
High risk -
AnimalBoehringer Ingelheim Animal Health USA
FDA warned Boehringer Ingelheim Animal Health USA that Senvelgo promotional materials falsely claimed safety and effectiveness in previously insulin-treated cats.
High risk -
AnimalSamuel Rodriguez dba KiloKennelzz
KiloKennelzz marketed Green Monster, an unapproved injectable animal drug, online with claims to treat dog diseases.
High risk -
AnimalEmbryll Life Sciences, Inc.
FDA warns Embryll Life Sciences that it sells unapproved Lanomax eye drops to treat cataracts in animals.
High risk -
AnimalEssential Research, LLC
FDA warned Essential Research that its Chocolate Rescue for Dogs is an unapproved new animal drug sold with unproven treatment claims.
High risk -
FoodEffingham Equity
Effingham Equity's Illinois animal feed mill used grain above FDA mycotoxin limits and lacked adequate hazard controls.
High risk